CEO Mark Capone tells the story of one patient and how genetic testing might have saved her life, as well as how it impacted the life of her daughter. “The story reminds me how important our efforts are here at Myriad.”

Myriad Genetics at J.P. Morgan Healthcare Conference

Paul J. Diaz, president and chief executive officer, Bryan Riggsbee, chief financial officer, and Dale Muzzey, chief scientific officer, presented at the 41st annual J.P. Morgan (JPM) Healthcare Conference.